Fred Alger Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-26,000
| Closed | -$990K | – | 546 |
|
|
2019
Q1 | $990K | Buy |
26,000
+13,000
| +100% | +$495K | ﹤0.01% | 334 |
|
|
2018
Q4 | $559K | Sell |
13,000
-47,279
| -78% | -$2.03M | ﹤0.01% | 347 |
|
|
2018
Q3 | $2.96M | Buy |
+60,279
| New | +$2.96M | 0.01% | 260 |
|
|
2017
Q2 | – | Sell |
-133,388
| Closed | -$6.08M | – | 567 |
|
|
2017
Q1 | $6.08M | Sell |
133,388
-3,666
| -3% | -$167K | 0.03% | 207 |
|
|
2016
Q4 | $4.43M | Buy |
137,054
+36,265
| +36% | +$1.17M | 0.02% | 191 |
|
|
2016
Q3 | $3.45M | Sell |
100,789
-98,229
| -49% | -$3.36M | 0.02% | 221 |
|
|
2016
Q2 | $6.71M | Sell |
199,018
-1,658,544
| -89% | -$55.9M | 0.04% | 190 |
|
|
2016
Q1 | $98.4M | Buy |
1,857,562
+1,079,877
| +139% | +$57.2M | 0.5% | 54 |
|
|
2015
Q4 | $59.7M | Buy |
777,685
+569,206
| +273% | +$43.7M | 0.29% | 83 |
|
|
2015
Q3 | $8.57M | Sell |
208,479
-31,552
| -13% | -$1.3M | 0.05% | 208 |
|
|
2015
Q2 | $17M | Sell |
240,031
-73,705
| -23% | -$5.21M | 0.08% | 164 |
|
|
2015
Q1 | $27.9M | Sell |
313,736
-58,359
| -16% | -$5.19M | 0.13% | 131 |
|
|
2014
Q4 | $33M | Buy |
372,095
+84,085
| +29% | +$7.45M | 0.16% | 118 |
|
|
2014
Q3 | $27.9M | Buy |
288,010
+149,717
| +108% | +$14.5M | 0.14% | 130 |
|
|
2014
Q2 | $12.7M | Buy |
+138,293
| New | +$12.7M | 0.06% | 243 |
|